Core Insights - West Pharmaceutical Services, Inc. is a global leader in innovative solutions for injectable drug administration, emphasizing its role in ensuring safe and effective drug delivery [1][3]. Company Overview - West Pharmaceutical Services, Inc. generated $2.95 billion in net sales in its fiscal year 2023 [4]. - The company operates with approximately 10,000 team members across 50 sites worldwide, delivering around 43 billion components and devices annually [3][4]. - West is publicly traded on the New York Stock Exchange under the ticker symbol WST and is included in the Standard & Poor's 500 index [4]. Upcoming Events - Key executives, including Cindy Reiss-Clark, Chad Winters, and John Sweeney, will present at the CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference on January 14, 2025, at 10:15 a.m. ET [1]. - A live audio webcast of the presentation will be available on the company's website [2].
West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference